发明名称 |
OPTIMIZATION METHOD OF TNFR2 |
摘要 |
PURPOSE: An optimizing method of tumor necrosis factor receptor type 2 (TNFR2) is provided to verify if an O-glycosylation site and an N-glycosylation site are unnecessary in TNFR2-Fc and to remove the sites, thereby minimizing side effects of a drug because the sites are smaller than the size of full length TNFR2 protein. CONSTITUTION: A method for improving efficiency of TNFR2 comprises the steps of removing an O-glycosylation site, an N-glycosylation site, or O-glycosylation and N-glycosylation sites. The O-glycosylation site is 202th to 252th amino acids from N-terminal of TNFR2. The N-glycosylation site is 28th, 31st, or 34th amino acid from N-terminal of TNFR2. The 34th amino acid (proline) is substituted with asparagine in the N-glycosylation site. |
申请公布号 |
KR20130110577(A) |
申请公布日期 |
2013.10.10 |
申请号 |
KR20120032642 |
申请日期 |
2012.03.29 |
申请人 |
A&R THERAPEUTICS CO., LTD. |
发明人 |
YOO, SEOK HO;PARK, YOUNG WOO;PARK, JAE EUN;JANG, MYEONG HEE;KIM, HYE NAN |
分类号 |
C07K14/705;A61K38/17;A61P29/00 |
主分类号 |
C07K14/705 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|